Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Siccaprotect
- Development stage
- Unknown
- Lead developer
- URSAPHARM Arzneimittel
- Modality
- Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
Siccaprotect is an ophthalmic solution indicated for the symptomatic treatment of dry eye (keratoconjunctivitis sicca) and the protection of the ocular surface. It is a combination product containing polyvinyl alcohol and dexpanthenol. Polyvinyl alcohol acts as a lubricant and film-forming agent that increases the viscosity of the tear film, thereby stabilizing it and reducing the evaporation of natural tears. Dexpanthenol, a precursor of pantothenic acid (Vitamin B5), promotes the regeneration of the corneal and conjunctival epithelium and supports wound healing. Developed and manufactured by Ursapharm, Siccaprotect is used to alleviate irritation, burning, and dryness of the eyes, particularly when these symptoms are associated with environmental factors or underlying tear film instability.
- Brand names
- Siccaprotect
02
Targets
CoA (Coenzyme A)
Beyond the preview
Go deeper on Siccaprotect.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Siccaprotect.